Genitourinary Cancers Symposium Press Program Announced
Featured research includes:
- A study exploring the heart-related side effects (cardiotoxicity) of the targeted therapy sunitinib in patients with kidney cancer or gastrointestinal stromal tumors
- A study to assess the effectiveness of radiation therapy in men whose PSA levels continued to rise after receiving radical prostatectomy for prostate cancer
- A study evaluating the causes of death among elderly men diagnosed with localized prostate cancer who did not undergo treatment for the disease, to determine the potential for "watchful waiting" versus active treatment
- A study examining the reasons for the underuse of an equally effective and less invasive procedure for removing small kidney tumors, compared to total removal of the kidney (procedures are comparable to lumpectomy versus mastectomy in breast cancer)
In addition to the presscast prior to the Symposium, a working newsroom will be available at the meeting for reporters. Experts will be available onsite for comment and perspective.
The Genitourinary Cancers Symposium will take place February 14-16 at the San Francisco Marriott and will feature more than 500 abstracts on cancers of the testis, bladder, kidney and prostate. These cancers are diagnosed in more than 325,000 people in the U.S. every year. The Symposium will alternate with the Prostate Cancer Symposium every other year.
Three leading medical specialty societies co-sponsor the three-day, multidisciplinary symposium including the American Society of Clinical Oncology (ASCO), the American Society for Therapeutic Radiology and Oncology (ASTRO) and the Society of Urologic Oncology (SUO).
Media Registration: To register to attend the meeting, visit http://www.asco.org/presscenter
. About the American Society of Clinical Oncology (ASCO)
The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 25,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter. Patient-oriented cancer information is available at http://www.plwc.org.
About the American Society for Therapeutic Radiology and Oncology (ASTRO)
ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on ASTRO, visit http://www.astro.org. For more information on radiation therapy as a treatment option, visit http://www.rtanswers.org.
About the Society of Urologic Oncology (SUO)
The Society of Urologic Oncology (SUO) is the Nation's preeminent professional organization representing urologic oncologists that hold specific expertise in the study and treatment of genitourinary malignancies. In recognition of the multidisciplinary efforts involved in the study and treatment of genitourinary malignancies, the Society seeks to incorporate multiple disciplines in order to improve the care of patients with malignant urologic disease. Society of Urologic Oncology
Simpozion de cancer genito-urinarã program de presã a anunþat - Genitourinary Cancers Symposium Press Program Announced - articole medicale engleza - startsanatate